Maha Katabi - Profile and Investment Details

Investor Profile

Maha Katabi is a Hedge Fund, Venture Capital, Private Equity Firm, Investment Partner, Investor based in Quebec, Canada with a diverse investment portfolio that includes companies such as ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics, Amplyx Pharmaceuticals, Marea Therapeutics, Sorbent Therapeutics, Visen Pharmaceuticals, Versartis, Auris Medical, Aerovate Therapeutics, Medeor Therapeutics, Guavus, Edge Therapeutics, NorthSea TherapeuticsAthira Pharma, Ascendis Pharma, Audentes Therapeutics, CinCor Pharma, Karuna Therapeutics, Star Therapeutics, Bolt Biotherapeutics, Vestagen Technical Textiles, InCarda Therapeutics, Ziarco, Pionyr Immunotherapeutics, Invitae, AFYX Therapeutics, XyloCor Therapeutics, Natera, LYSOGENE, Neurana Pharmaceuticals, Kiniksa Pharmaceuticals, Aeovian Pharmaceuticals, Principia Biopharma, RayzeBio, Innocoll Holdings, Quanta Therapeutics, NuCana BioMed, ZS Pharma, Vera Therapeutics, Inc., NextCure, Aerovate Therapeutics, Inc., ConteXtream, Chiasma, Aclaris Therapeutics, Vera Therapeutics, Checkmate Pharmaceuticals, First Aid Shot Therapy, Apellis Pharmaceuticals, McPhy, Amplyx Pharmaceuticals, Inc, Civitas Therapeutics, Aiolos Bio, Crocus Technology, Atsena Therapeutics, Rainier Therapeutics, Galera Therapeutics, Gyroscope Therapeutics, ARTBIO, VelosBio, Antiva Biosciences, Intrepida Bio, Merus, Mirna Therapeutics, Akouos, Effector Therapeutics, Coherus Biosciences, aTyr Pharma, Inozyme, Exactis Innovation, Promedior, Iterum Therapeutics, ObsEva, Dauntless Pharmaceuticals, GYROSCOPE Tx, Spark Therapeutics, Entasis Therapeutics, . Over time, Maha Katabi has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Maha Katabi is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Genetics, Wellness, Women Founded, Investment Management, Life Science, Venture Fundraising, Finance, Biotechnology, Consumer Health, Drug Development, Electronic Health Records (EHR), Genomics, Health and Hospital Services, Innovation, Clinical Trials, FinTech, Hedge Funds, Innovation Management, Digital Health, Medical, Information Technology, B2B, Therapeutics, Media and Entertainment, Pharmaceuticals may find it worthwhile to explore potential connections with Maha Katabi, as their portfolio suggests a familiarity and interest in this area.

Understanding Maha Katabi’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.